LZTS2 antibody
Quick Overview for LZTS2 antibody (ABIN7115825)
Target
See all LZTS2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- LZTS2 antibody
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- leucine zipper, putative tumor suppressor 2
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000, IHC: 1:20-1:200
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months
-
Expiry Date
- 12 months
-
-
- LZTS2 (Leucine Zipper, Putative Tumor Suppressor 2 (LZTS2))
-
Alternative Name
- LZTS2
-
Background
-
Synonyms: Leucine zipper putative tumor suppressor 2 (hLZTS2)|Protein LAPSER1|LZTS2|KIAA1813|LAPSER1
Background: Negative regulator of katanin-mediated microtubule severing and release from the centrosome. Required for central spindle formation and the completion of cytokinesis. May negatively regulate axonal outgrowth by preventing the formation of microtubule bundles that are necessary for transport within the elongating axon. Negative regulator of the Wnt signaling pathway. Represses beta-catenin-mediated transcriptional activation by promoting the nuclear exclusion of beta-catenin.
-
Molecular Weight
- 70-80 kDa
-
Gene ID
- 84445
-
UniProt
- Q9BRK4
Target
-